Drug Type ASO |
Synonyms- |
Action modulators |
Mechanism SIRT1 modulators(NAD-dependent deacetylase sirtuin 1 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Discovery | - | 26 Dec 2024 | |
| Metabolic Dysfunction Associated Steatohepatitis | Discovery | - | 26 Dec 2024 | |
| Musculoskeletal Abnormalities | Discovery | - | 26 Dec 2024 | |
| Other Diseases | Discovery | - | 26 Dec 2024 | |
| Pulmonary Fibrosis | Discovery | - | 26 Dec 2024 |





